Literature DB >> 11083682

Atopy influences exhaled nitric oxide levels in adult asthmatics.

L P Ho1, F T Wood, A Robson, J A Innes, A P Greening.   

Abstract

STUDY
OBJECTIVE: To examine whether atopy influences exhaled nitric oxide (NO) levels in adults with established asthma.
SETTING: Specialist respiratory unit in a university teaching hospital. PATIENTS: Twenty-eight asthmatics (mean FEV(1), 85.7%) receiving short-acting inhaled bronchodilators and a range of inhaled steroids (0 to 4,000 microg/d).
INTERVENTIONS: Subjects were studied on two occasions, 5 to 7 days apart, between September and March. MEASUREMENTS AND
RESULTS: On the first day, FEV(1), exhaled NO, and histamine challenge were performed. On the second day, exhaled NO, total IgE, and skin-prick testing to six common allergens were conducted. Exhaled NO was measured with the single exhalation method. We found exhaled NO levels to correlate positively with total IgE (r = 0.43, p = 0.02) and number of positive skin-prick tests (p = 0. 002). By contrast, there was no significant correlation between exhaled NO and FEV(1) or the provocative concentration causing a 20% fall in FEV(1). Subanalyses of steroid-treated and steroid-naive patients in this group revealed the same findings.
CONCLUSION: Exhaled NO levels in asthmatics correlate more closely with atopy than with bronchial hyperreactivity and lung function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083682     DOI: 10.1378/chest.118.5.1327

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Sputum proteomics in inflammatory and suppurative respiratory diseases.

Authors:  Robert D Gray; Gordon MacGregor; Donald Noble; Margaret Imrie; Maria Dewar; A Christopher Boyd; J Alastair Innes; David J Porteous; Andrew P Greening
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

Review 2.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

3.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

4.  Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children.

Authors:  P J Franklin; S W Turner; P N Le Souëf; S M Stick
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

5.  Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide.

Authors:  Annamari Rouhos; Annette Kainu; Jouko Karjalainen; Ari Lindqvist; Päivi Piirilä; Seppo Sarna; Tari Haahtela; Anssi R A Sovijärvi
Journal:  Clin Respir J       Date:  2008-07       Impact factor: 2.570

6.  Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: A cross-sectional study in bronchial asthma and allergic rhinitis.

Authors:  Nitesh Gupta; Nitin Goel; Raj Kumar
Journal:  Lung India       Date:  2014-10

Review 7.  Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.

Authors:  Noora Louhelainen; Marjukka Myllärniemi; Irfan Rahman; Vuokko L Kinnula
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

8.  Reproducibility of exhaled nitric oxide in smokers and non-smokers: relevance for longitudinal studies.

Authors:  Abraham Bohadana; Jean-Pierre Michaely; Dan Teculescu; Pascal Wild
Journal:  BMC Pulm Med       Date:  2008-02-28       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.